[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367340-105":59,"doc-detail-367340-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","unveiling-the-novel-anti-tumor-potential-of-digitonin-a-steroidal-saponin-in-gastric-cancer-a-network-pharmacology-and-experimental-validation-study","Unveiling the Novel Anti-Tumor Potential of Digitonin, a Steroidal Saponin, in Gastric Cancer - A Network Pharmacology and Experimental Validation Study","","Gastric cancer remains a leading cause of cancer-related mortality, especially in advanced stages with limited effective therapies. Digitonin, a steroidal saponin reported to have anti-neoplastic activity in multiple cancers, has an insufficiently defined mechanism in gastric cancer. This study combines network pharmacology target discovery with cell and in vivo experiments, showing digitonin suppresses proliferation, migration, and invasion, and blocks HSP90AA1 and NFKB1 signaling to induce apoptosis and inhibit tumor growth.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/unveiling-the-novel-anti-tumor-potential-of-digitonin-a-steroidal-saponin-in-gastric-cancer-a-network-pharmacology-and-experimental-validation-study/367340/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/unveiling-the-novel-anti-tumor-potential-of-digitonin-a-steroidal-saponin-in-gastric-cancer-a-network-pharmacology-and-experimental-validation-study/367340.png","ImageObject",300,407,{"name":92,"@type":93},"Rhys","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research focus of this study?","Question",{"text":112,"@type":113},"The study investigates digitonin’s anti-tumor potential in gastric cancer and aims to clarify its mechanisms using network pharmacology plus experimental validation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was digitonin’s effect on gastric cancer cells evaluated?",{"text":117,"@type":113},"Digitonin’s impact on proliferation, invasion, and migration was assessed using CCK-8, colony formation, wound healing, and transwell assays.",{"name":119,"@type":110,"acceptedAnswer":120},"Which targets and signaling pathways were identified and validated?",{"text":121,"@type":113},"Network pharmacology highlighted key pathways including HIF-1α, Ras, and PI3K-Akt, with HSP90AA1 and NFKB1 as central targets; docking and experiments confirmed digitonin suppresses HSP90AA1 and inhibits nuclear translocation of NFKB1, promoting apoptosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367340,1790874671,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Drug Design, Development and Therapy  \nOpen Access Full Text Article ORIGINAL RESEARCH  \nUnveiling the Novel Anti -Tumor Potential of Digitonin, a Steroidal Saponin, in Gastric Cancer:  \nA Network Pharmacology and Experimental Validation Study  \nDongdong Lu 1 , 2 , Leijie Huang 1 , Chunyan Weng 2  \n1Department of Gastroenterology, Ningbo No. 2 Hospital, Ningbo, Zhejiang Province, 315000, People’s Republic of China; 2Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang Province, 310000, People’s Republic of China  \nCorrespondence: Chunyan Weng, Email [Springsinging2019@163.com](Springsinging2019@163.com)  \n\n| Background: Gastric cancer (GC) remains a leading cause of cancer-related mortality, with limited effective treatment options for advanced stages. As a steroidal saponin with documented anti-neoplastic properties in multiple cancers, digitonin’s mode of action in GC pathogenesis has yet to be fully elucidated. This research focused on exploring the potential of Digitonin in GC treatment using a combination of network pharmacology and experimental validation.\u003Cbr>Methods: The inhibitory effects of Digitonin on the proliferation, invasion, and migration of gastric cancer cells were evaluated using CCK-8, colony formation, wound healing, and transwell assays. Key targets of Digitonin were identified through network pharmacology. Molecular docking and various experiments, including Western blot, immunofluorescence, and a subcutaneous xenograft model, were used for validation.\u003Cbr>Results: Digitonin exhibited stronger cytotoxicity against GC cells and significantly inhibited GC cell proliferation, migration, and invasion. Network pharmacology analysis revealed that the core targets of Digitonin are involved in key cancer-related signaling pathways, including HIF-1α, Ras, and PI3K-Akt pathways, with HSP90AA1 and NFKB1 identified as central targets. Further molecular docking, Western blotting, and immunofluorescence experiments confirmed that Digitonin significantly suppressed the expression of HSP90AA1 and inhibited the nuclear translocation of NFKB1, inducing cell apoptosis. Additionally, a subcutaneous xenograft model of GC further validated that Digitonin effectively inhibited tumor growth.\u003Cbr>Conclusion: Digitonin serves as a promising multi-target therapeutic agent for GC. This study underscores the potential of combining network pharmacology with traditional Chinese medicine to identify novel therapeutic targets and develop effective anti-cancer strategies. In addition, these findings suggest that digitonin could be a promising candidate for future clinical trials in GC treatment. Keywords: gastric cancer, digitonin, network pharmacology, HSP90AA1, NFKB1 |\n| --- |\n| Introduction\u003Cbr>As reported in the 2022 Global Cancer Statistics, gastric cancer (GC) is the 5th globally in both incidence and mortality.1 Due to its often late-stage diagnosis, the 5-year survival rate remains low.2 Despite recent advancements in treatment modalities, the prognosis for patients with advanced GC remains poor.3 Among them, targeted therapies have emerged asa promising approach to improve outcomes in GC by inhibiting specific molecular pathways involved in tumor growth and progression.4,5\u003Cbr>As a commonly utilized branch of integrative medicine, traditional Chinese medicine (TCM) is appreciated by cancer patients for its therapeutic benefits and minimal severe side effects. Saponins, a diverse group of natural compounds found in various medicinal herbs, have attracted attention for their broad bioactivities, including anticancer properties.6–9 Digitonin, a steroidal saponin derived from the Digitalis genus, has shown potential in cancer therapy by inducing |\n\nReceived: 4 December 2024  \nAccepted: 15 March 2025  \nPublished: 5 April 2025  \nDrug Design, Development and Therapy 2025:19 2653–2666 2653  \n© 2025 Lu et al. This work is pu","cbCaitQPIVeavJRb","https://ap.wps.com/l/cbCaitQPIVeavJRb","pdf",11237879,14,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Introduction\n# Network Pharmacology","[{\"question\":\"What is the main research focus of this study?\",\"answer\":\"The study investigates digitonin’s anti-tumor potential in gastric cancer and aims to clarify its mechanisms using network pharmacology plus experimental validation.\"},{\"question\":\"How was digitonin’s effect on gastric cancer cells evaluated?\",\"answer\":\"Digitonin’s impact on proliferation, invasion, and migration was assessed using CCK-8, colony formation, wound healing, and transwell assays.\"},{\"question\":\"Which targets and signaling pathways were identified and validated?\",\"answer\":\"Network pharmacology highlighted key pathways including HIF-1α, Ras, and PI3K-Akt, with HSP90AA1 and NFKB1 as central targets; docking and experiments confirmed digitonin suppresses HSP90AA1 and inhibits nuclear translocation of NFKB1, promoting apoptosis.\"}]","Unveiling the Novel Anti-Tumor Potential of Digitonin, a Steroidal Saponin, in Gastric Cancer - A Network Pharmacology and Experimental Validation Study | PDF",1790170368,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/873227164b86376b162db054beabde32.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f60b916589971b225dd0553f330e123.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f5f1cac81f4cbeb4f5769a6ed0d1fb7.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88e34903e881a8fcce472b66cae453d3.webp",980,1268]